Artificial Intelligence and Pathology: from Principles to Practice and Future Applications in Histomorphology and Molecular Profiling.

[1]  B. van Ginneken,et al.  Streaming Convolutional Neural Networks for End-to-End Learning With Multi-Megapixel Images , 2019, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[2]  A. Stenzinger,et al.  Strength in numbers: predicting response to checkpoint inhibitors from large clinical datasets , 2021, Cell.

[3]  Francesco Ciompi,et al.  Neural Image Compression for Gigapixel Histopathology Image Analysis , 2018, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[4]  Jakob Nikolas Kather,et al.  Deep learning in cancer pathology: a new generation of clinical biomarkers , 2020, British Journal of Cancer.

[5]  E. Cuppen,et al.  Study protocol: Whole genome sequencing Implementation in standard Diagnostics for Every cancer patient (WIDE) , 2020, BMC medical genomics.

[6]  T. Winter.  Malicious Adversarial Attacks on Medical Image Analysis. , 2020, AJR. American journal of roentgenology.

[7]  N. Kim,et al.  Identification of potential causal variants for premature ovarian failure by whole exome sequencing , 2020, BMC medical genomics.

[8]  N. Forkert,et al.  Machine Learning for Precision Medicine. , 2020, Genome.

[9]  Anmol Arora,et al.  Pathology training in the age of artificial intelligence , 2020, Journal of Clinical Pathology.

[10]  Howard Y. Chang,et al.  Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer’s and Parkinson’s diseases , 2020, Nature Genetics.

[11]  A. Phillippy,et al.  Strategic vision for improving human health at The Forefront of Genomics , 2020, Nature.

[12]  A. Shuaib,et al.  The Increasing Role of Artificial Intelligence in Health Care: Will Robots Replace Doctors in the Future? , 2020, International journal of general medicine.

[13]  Jon D. McAuliffe,et al.  Improving lung cancer risk stratification leveraging whole transcriptome RNA sequencing and machine learning across multiple cohorts , 2020, BMC Medical Genomics.

[14]  Bertalan Meskó,et al.  The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database , 2020, npj Digital Medicine.

[15]  E. Cuppen,et al.  1189O Validation of whole genome sequencing in routine clinical practice , 2020 .

[16]  Suchi Saria,et al.  Minimum information about clinical artificial intelligence modeling: the MI-CLAIM checklist , 2020, Nature Medicine.

[17]  Andrew H. Beck,et al.  Dense, high-resolution mapping of cells and tissues from pathology images for the interpretable prediction of molecular phenotypes in cancer , 2020, bioRxiv.

[18]  Pierre Courtiol,et al.  A deep learning model to predict RNA-Seq expression of tumours from whole slide images , 2020, Nature Communications.

[19]  Mark Robson,et al.  Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: A report from the ESMO Precision Medicine Working Group. , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

[20]  L. Füzesi,et al.  Number of pathologists in Germany: comparison with European countries, USA, and Canada , 2020, Virchows Archiv.

[21]  Alex H. Wagner,et al.  Collaborative, Multidisciplinary Evaluation of Cancer Variants Through Virtual Molecular Tumor Boards Informs Local Clinical Practices , 2020, JCO clinical cancer informatics.

[22]  A. Goldenberg,et al.  Machine learning approaches to drug response prediction: challenges and recent progress. , 2020, NPJ precision oncology.

[23]  A. Khosla,et al.  Machine learning-based identification of predictive features of the tumor micro-environment and vasculature in NSCLC patients using the IMpower150 study. , 2020 .

[24]  Roderic Guigó,et al.  PyHIST: A Histological Image Segmentation Tool , 2020, bioRxiv.

[25]  D. Ruderman,et al.  Deep learned tissue “fingerprints” classify breast cancers by ER/PR/Her2 status from H&E images , 2020, Scientific Reports.

[26]  H. McAneney,et al.  A scoping review and proposed workflow for multi-omic rare disease research , 2020, Orphanet Journal of Rare Diseases.

[27]  S. Gerke,et al.  Ethical and legal challenges of artificial intelligence-driven healthcare , 2020, Artificial Intelligence in Healthcare.

[28]  Shuhao Wang,et al.  Emerging role of deep learning‐based artificial intelligence in tumor pathology , 2020, Cancer communications.

[29]  Alex H. Wagner,et al.  A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer , 2020, Nature Genetics.

[30]  A. Stenzinger,et al.  Evaluation of a hybrid capture-based pan-cancer panel for analysis of treatment stratifying oncogenic aberrations and processes. , 2020, The Journal of molecular diagnostics : JMD.

[31]  Wojciech Samek,et al.  Toward Interpretable Machine Learning: Transparent Deep Neural Networks and Beyond , 2020, ArXiv.

[32]  S. Fröhling,et al.  Harmonization and Standardization of Panel-Based Tumor Mutational Burden (TMB) Measurement: Real-World Results and Recommendations of the QuIP Study. , 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[33]  Jeremy L. Warner,et al.  A Review of Precision Oncology Knowledgebases for Determining the Clinical Actionability of Genetic Variants , 2020, Frontiers in Cell and Developmental Biology.

[34]  M. Niranjan,et al.  Robust subspace methods for outlier detection in genomic data circumvents the curse of dimensionality , 2020, Royal Society Open Science.

[35]  David Capper,et al.  DNA-Methylation-based Classification of Paediatric Brain Tumours. , 2020, Neuropathology and applied neurobiology.

[36]  David T. W. Jones,et al.  Machine learning workflows to estimate class probabilities for precision cancer diagnostics on DNA methylation microarray data , 2020, Nature Protocols.

[37]  B. van Ginneken,et al.  Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study. , 2020, The Lancet. Oncology.

[38]  Jakob Nikolas Kather,et al.  Pan-cancer image-based detection of clinically actionable genetic alterations , 2019, Nature Cancer.

[39]  Alexander W. Jung,et al.  Pan-cancer computational histopathology reveals mutations, tumor composition and prognosis , 2019, Nature Cancer.

[40]  Klaus-Robert Müller,et al.  Resolving challenges in deep learning-based analyses of histopathological images using explanation methods , 2019, Scientific Reports.

[41]  Alexander Binder,et al.  Interpretable Deep Neural Network to Predict Estrogen Receptor Status from Haematoxylin-Eosin Images , 2020, AI and ML for Digital Pathology.

[42]  Theodoros Evgeniou,et al.  Algorithms on regulatory lockdown in medicine , 2019, Science.

[43]  Alexander V Penson,et al.  Development of Genome-Derived Tumor Type Prediction to Inform Clinical Cancer Care. , 2019, JAMA oncology.

[44]  George P Patrinos,et al.  Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics. , 2019, Omics : a journal of integrative biology.

[45]  Shradha Mukherjee.  Genomics-Guided Immunotherapy for Precision Medicine in Cancer. , 2019, Cancer biotherapy & radiopharmaceuticals.

[46]  Helen Pitman,et al.  Artificial intelligence in digital pathology: a roadmap to routine use in clinical practice , 2019, The Journal of pathology.

[47]  Klaus-Robert Müller,et al.  Machine learning analysis of DNA methylation profiles distinguishes primary lung squamous cell carcinomas from head and neck metastases , 2019, Science Translational Medicine.

[48]  D. Heim,et al.  Histomorphological and molecular profiling: friends not foes! Morpho‐molecular analysis reveals agreement between histological and molecular profiling , 2019, Histopathology.

[49]  A. Madabhushi,et al.  Artificial intelligence in digital pathology — new tools for diagnosis and precision oncology , 2019, Nature Reviews Clinical Oncology.

[50]  Stephen S. F. Yip,et al.  Multi-Field-of-View Deep Learning Model Predicts Nonsmall Cell Lung Cancer Programmed Death-Ligand 1 Status from Whole-Slide Hematoxylin and Eosin Images , 2019, Journal of pathology informatics.

[51]  Thomas J. Fuchs,et al.  Clinical-grade computational pathology using weakly supervised deep learning on whole slide images , 2019, Nature Medicine.

[52]  L. Ivashkiv,et al.  Interferon target-gene expression and epigenomic signatures in health and disease , 2019, Nature Immunology.

[53]  Anand S Dighe,et al.  Machine Learning and Other Emerging Decision Support Tools. , 2019, Clinics in laboratory medicine.

[54]  Fabrice Andre,et al.  Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update-Integration of Results From TAILORx. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[55]  Christopher Y. Park,et al.  Whole-genome deep-learning analysis identifies contribution of noncoding mutations to autism risk , 2019, Nature Genetics.

[56]  Phedias Diamandis,et al.  Physician perspectives on integration of artificial intelligence into diagnostic pathology , 2019, npj Digital Medicine.

[57]  Jakob Nikolas Kather,et al.  Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer , 2019, Nature Medicine.

[58]  C. von Kalle,et al.  Defective homologous recombination DNA repair as therapeutic target in advanced chordoma , 2019, Nature Communications.

[59]  K. Müller,et al.  Unmasking Clever Hans predictors and assessing what machines really learn , 2019, Nature Communications.

[60]  Geert J. S. Litjens,et al.  Quantifying the effects of data augmentation and stain color normalization in convolutional neural networks for computational pathology , 2019, Medical Image Anal..

[61]  C. Denkert,et al.  DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancer , 2019, Modern Pathology.

[62]  Shaoqun Zeng,et al.  From Detection of Individual Metastases to Classification of Lymph Node Status at the Patient Level: The CAMELYON17 Challenge , 2019, IEEE Transactions on Medical Imaging.

[63]  P. Denéfle,et al.  The contribution of genomics in the medicine of tomorrow, clinical applications and issues. , 2019, Therapie.

[64]  Lon Phan,et al.  SPDI: Data Model for Variants and Applications at NCBI , 2019, bioRxiv.

[65]  T A Chan,et al.  Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[66]  Inioluwa Deborah Raji,et al.  Model Cards for Model Reporting , 2018, FAT.

[67]  Klaus-Robert Müller,et al.  iNNvestigate neural networks! , 2018, J. Mach. Learn. Res..

[68]  D. Erhan,et al.  A Benchmark for Interpretability Methods in Deep Neural Networks , 2018, NeurIPS.

[69]  David F. Steiner,et al.  Impact of Deep Learning Assistance on the Histopathologic Review of Lymph Nodes for Metastatic Breast Cancer , 2018, The American journal of surgical pathology.

[70]  Been Kim,et al.  Sanity Checks for Saliency Maps , 2018, NeurIPS.

[71]  Sander Canisius,et al.  Molecular characterization of breast and lung tumors by integration of multiple data types with functional sparse-factor analysis , 2018, PLoS Comput. Biol..

[72]  K-R Müller,et al.  Scoring of tumor-infiltrating lymphocytes: From visual estimation to machine learning. , 2018, Seminars in cancer biology.

[73]  N. Razavian,et al.  Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning , 2018, Nature Medicine.

[74]  E. King,et al.  Pan-cancer deconvolution of tumour composition using DNA methylation , 2018, Nature Communications.

[75]  Martin Sill,et al.  Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience , 2018, Acta Neuropathologica.

[76]  A. Jeyasekharan,et al.  Biomarkers for Homologous Recombination Deficiency in Cancer , 2018, Journal of the National Cancer Institute.

[77]  David T. W. Jones,et al.  Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations , 2018, Acta Neuropathologica.

[78]  Masaru Ishii,et al.  Towards computational fluorescence microscopy: Machine learning-based integrated prediction of morphological and molecular tumor profiles , 2018, ArXiv.

[79]  Yifan Peng,et al.  LitVar: a semantic search engine for linking genomic variant data in PubMed and PMC , 2018, Nucleic Acids Res..

[80]  Jochen K. Lennerz,et al.  Artificial Intelligence Approach for Variant Reporting , 2018, JCO clinical cancer informatics.

[81]  Till Acker,et al.  DNA methylation-based classification of central nervous system tumours , 2018, Nature.

[82]  T. Hermanns,et al.  Automated Gleason grading of prostate cancer tissue microarrays via deep learning , 2018, Scientific Reports.

[83]  I. Shmulevich,et al.  Epigenetic profiling for the molecular classification of metastatic brain tumors , 2018, bioRxiv.

[84]  J. Cuzick,et al.  Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor–Positive Breast Cancer , 2018, JAMA oncology.

[85]  Max Welling,et al.  Attention-based Deep Multiple Instance Learning , 2018, ICML.

[86]  Wojciech Samek,et al.  Methods for interpreting and understanding deep neural networks , 2017, Digit. Signal Process..

[87]  Klaus-Robert Müller,et al.  Learning how to explain neural networks: PatternNet and PatternAttribution , 2017, ICLR.

[88]  P. Fasching,et al.  Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy. , 2018, The Lancet. Oncology.

[89]  H. Brenner,et al.  Genome-wide DNA methylation analysis reveals a prognostic classifier for non-metastatic colorectal cancer (ProMCol classifier) , 2017, Gut.

[90]  L. Harris,et al.  Gene Expression Assays for Early-Stage Hormone Receptor–Positive Breast Cancer: Understanding the Differences , 2017, JNCI cancer spectrum.

[91]  C. von Kalle,et al.  Precision oncology based on omics data: The NCT Heidelberg experience , 2017, International journal of cancer.

[92]  Z. Herceg,et al.  Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors , 2017, The Journal of clinical endocrinology and metabolism.

[93]  Gianluca Bontempi,et al.  DNA methylation–based immune response signature improves patient diagnosis in multiple cancers , 2017, The Journal of clinical investigation.

[94]  Roland Eils,et al.  The whole-genome landscape of medulloblastoma subtypes , 2017, Nature.

[95]  C. Chakraborty,et al.  An Advanced Deep Learning Approach for Ki-67 Stained Hotspot Detection and Proliferation Rate Scoring for Prognostic Evaluation of Breast Cancer , 2017, Scientific Reports.

[96]  Martin Wattenberg,et al.  SmoothGrad: removing noise by adding noise , 2017, ArXiv.

[97]  Scott Lundberg,et al.  A Unified Approach to Interpreting Model Predictions , 2017, NIPS.

[98]  Martin Sill,et al.  DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. , 2017, The Lancet. Oncology.

[99]  Avanti Shrikumar,et al.  Learning Important Features Through Propagating Activation Differences , 2017, ICML.

[100]  Michel E. Vandenberghe,et al.  Relevance of deep learning to facilitate the diagnosis of HER2 status in breast cancer , 2017, Scientific Reports.

[101]  Jianhui Chen,et al.  Automated grading of breast cancer histopathology using cascaded ensemble with combination of multi-level image features , 2017, Neurocomputing.

[102]  Ankur Taly,et al.  Axiomatic Attribution for Deep Networks , 2017, ICML.

[103]  Bram van Ginneken,et al.  A survey on deep learning in medical image analysis , 2017, Medical Image Anal..

[104]  Max Welling,et al.  Visualizing Deep Neural Network Decisions: Prediction Difference Analysis , 2017, ICLR.

[105]  Sebastian Thrun,et al.  Dermatologist-level classification of skin cancer with deep neural networks , 2017, Nature.

[106]  Jean-Philippe Fortin,et al.  Preprocessing, normalization and integration of the Illumina HumanMethylationEPIC array with minfi , 2016, bioRxiv.

[107]  Abhishek Das,et al.  Grad-CAM: Visual Explanations from Deep Networks via Gradient-Based Localization , 2016, 2017 IEEE International Conference on Computer Vision (ICCV).

[108]  K. Müller,et al.  Explaining nonlinear classification decisions with deep Taylor decomposition , 2015, Pattern Recognit..

[109]  Alexander Binder,et al.  Evaluating the Visualization of What a Deep Neural Network Has Learned , 2015, IEEE Transactions on Neural Networks and Learning Systems.

[110]  P. Starostik.  Clinical mutation assay of tumors: new developments , 2017, Anti-cancer drugs.

[111]  R. Tothill,et al.  Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis. , 2016, The Lancet. Oncology.

[112]  L. V. van't Veer,et al.  70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer. , 2016, The New England journal of medicine.

[113]  Laxmi Parida,et al.  Watson for Genomics: Moving Personalized Medicine Forward. , 2016, Trends in cancer.

[114]  Rachel G Liao,et al.  A federated ecosystem for sharing genomic, clinical data , 2016, Science.

[115]  Raymond Dalgleish,et al.  HGVS Recommendations for the Description of Sequence Variants: 2016 Update , 2016, Human mutation.

[116]  Roland Eils,et al.  Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes. , 2016, Cancer cell.

[117]  Roland Eils,et al.  New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs , 2016, Cell.

[118]  M. Gerstein,et al.  Quantification of private information leakage from phenotype-genotype data: linking attacks , 2016, Nature Methods.

[119]  M. Esteller,et al.  Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences , 2015, Epigenomics.

[120]  Jian Sun,et al.  Deep Residual Learning for Image Recognition , 2015, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).

[121]  Alexander Binder,et al.  Analyzing Classifiers: Fisher Vectors and Deep Neural Networks , 2015, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).

[122]  W. Weichert,et al.  Next-generation sequencing: hype and hope for development of personalized radiation therapy? , 2015, Radiation oncology.

[123]  Alexander Binder,et al.  On Pixel-Wise Explanations for Non-Linear Classifier Decisions by Layer-Wise Relevance Propagation , 2015, PloS one.

[124]  Geoffrey E. Hinton,et al.  Deep Learning , 2015, Nature.

[125]  Thomas Brox,et al.  U-Net: Convolutional Networks for Biomedical Image Segmentation , 2015, MICCAI.

[126]  Gary D Bader,et al.  Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups. , 2015, Cancer cell.

[127]  Alla Alexandrovna Kornienko,et al.  Knowledge in Artificial Intelligence Systems: Searching the Strategies for Application☆ , 2015 .

[128]  Thomas Brox,et al.  Striving for Simplicity: The All Convolutional Net , 2014, ICLR.

[129]  Luca Maria Gambardella,et al.  Assessment of algorithms for mitosis detection in breast cancer histopathology images , 2014, Medical Image Anal..

[130]  Andrew Zisserman,et al.  Very Deep Convolutional Networks for Large-Scale Image Recognition , 2014, ICLR.

[131]  Carsten Denkert,et al.  Standardized Ki67 Diagnostics Using Automated Scoring—Clinical Validation in the GeparTrio Breast Cancer Study , 2014, Clinical Cancer Research.

[132]  Serena Nik-Zainal,et al.  Mechanisms underlying mutational signatures in human cancers , 2014, Nature Reviews Genetics.

[133]  E. Li,et al.  DNA methylation in mammals. , 2014, Cold Spring Harbor perspectives in biology.

[134]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[135]  Jack Cuzick,et al.  Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[136]  L. Shaffer,et al.  Cytogenetic Nomenclature: Changes in the ISCN 2013 Compared to the 2009 Edition , 2013, Cytogenetic and Genome Research.

[137]  Geoffrey E. Hinton,et al.  ImageNet classification with deep convolutional neural networks , 2012, Commun. ACM.

[138]  F. Markowetz,et al.  Quantitative Image Analysis of Cellular Heterogeneity in Breast Tumors Complements Genomic Profiling , 2012, Science Translational Medicine.

[139]  Daniel Heim,et al.  Detection and Segmentation of Cell Nuclei in Virtual Microscopy Images: A Minimum-Model Approach , 2012, Scientific Reports.

[140]  Thomas Lengauer,et al.  A DNA methylation fingerprint of 1628 human samples. , 2011, Genome research.

[141]  R. Greil,et al.  A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors , 2011, Clinical Cancer Research.

[142]  Motoaki Kawanabe,et al.  How to Explain Individual Classification Decisions , 2009, J. Mach. Learn. Res..

[143]  A. Nobel,et al.  Supervised risk predictor of breast cancer based on intrinsic subtypes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[144]  M. Cronin,et al.  A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.

[145]  Yudong D. He,et al.  A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .

[146]  R. Tibshirani,et al.  Diagnosis of multiple cancer types by shrunken centroids of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[147]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[148]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[149]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[150]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.